期刊文献+

雄激素受体及其辅调节因子在肥胖及胰岛素抵抗中作用的研究进展 被引量:3

Current study of the roles of androgen receptor and its co-factors in obesity and insulin resistance
原文传递
导出
摘要 雄激素受体(androgen receptor,AR)是核受体超家族的成员,主要通过与配体(雄激素)结合的方式发挥其生物学功能。AR在调节男性精子生成和发育,维持男性第二性征等方面起重要作用。此外,AR在前列腺癌、肝癌等疾病的发生发展中起重要作用。更有趣的是,近来研究发现,AR及其介导的靶基因转录在抵抗肥胖,抑制机体产生胰岛素抵抗中也发挥着不可忽视的作用。AR的辅助调节因子参与调控AR介导的基因转录,通过不同的分子机制影响着AR的活性,并且影响机体能量代谢活动。现就AR结构与功能、AR的辅助调节因子的作用机制及其对脂代谢、胰岛素抵抗等影响进行综述。 Androgen receptor (AR) is a member of nuclear receptor superfamily, and mainly exerts its biological function in a ligand-dependent manner. AR plays an important role in regulating the male sperm production and development, maintaining male secondary sex characteristics, and so on. Furthermore, AR is implicated in the progression of prostate cancer, liver cancer, and other diseases. More interestingly, recent studies have found that AR and its target gene play important roles which cannot be ignored on mediating against obesity, inhibiting the body's resistance to insulin. Cofactors of AR are capable to regulate the transcription of genes, which are mediated by AR, affect the activity of AR by the different molecular mechanisms, and affect the body's metabolic activity. We reveiw the structure and the function of AR, the mechanism of cofactor action and its effects on the lipid metabolism, insulin resistance and so on.
出处 《生命科学》 CSCD 2015年第4期453-461,共9页 Chinese Bulletin of Life Sciences
基金 国家自然科学基金项目(31171259,31271-3 6 4) 国家重点基础研究发展计划(“9 7 3”项目)(2013CB945200) 教育部科学技术研究项目(v201308)
关键词 雄激素受体 辅助调节因子 胰岛素抵抗 肥胖 糖尿病 androgen receptor co-factors insulin resistance obesity diabetes
  • 相关文献

参考文献1

二级参考文献28

  • 1Stellato R, Feldman H, Hamdy O, Horton E, McKinlay JB. Testosterone, sex hormone?binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study. Diabetes Care 2000; 23: 490-4.
  • 2Isidro ML. Sexual dysfunction in men with type 2 diabetes. Past grad MedJ2012; 88: 152-9.
  • 3Lu CC, Jiann BP, Sun CC, Lam HC, Chu CH et al. Association of glycemic control with risk of erectile dysfunction in men with type 2 diabetes. J Sex Med2009; 6: 1719-28.
  • 4Rendell MS, Rajler J, Wicker PA, Smith MO. Sildenafil for treatment of erectile dysfunction in men with diabetes. JAMA 1999; 281: 421-6.
  • 5Kalinchenko S, Kozlov G, Gontcharov N, Katsiya G. Oral testosterone undecanoate reverses erectile dysfunction associated with diabetes mellitus in patients failing on sildenafil citrate therapy alone. Aging Male 2003; 6: 94-9.
  • 6Jones TH, Arver S, Behre HM, BuvatJ, Meuleman E et al. Testosterone replacement in hypogonadal men with type 2 diabetes andlor metabolic syndrome (the TIMES2 study). Diabetes Care 2011; 34: 828-37.
  • 7Cao J, Li J, Hao W, Li X, Wang H et al. Correlation of sex hormone and androgen receptor with diabetes mellitus in elderly men. Aging Male 2011; 14: 162-7.
  • 8Harkonen K, Huhtaniemi I, Makinen J, Hubler O, Irjala K et al. The polymorphic androgen receptor gene CAG repeat, pituitary-testicular function and andropausal symptoms in ageing men. Int J Androl 2003; 26: 187-94.
  • 9Bennett NC, Gardiner RA, Hooper JD, Johnson OW, Gobe GC. Molecularcell biology of androgen receptor signalling. Int J Biochem Cell Bioi 2010; 42: 813-27.
  • 10Fraga MF, Ballestar E, Paz MF, Ropero S, Setien F et al. Epigenetic differences arise during the lifetime of monozygotic twins. Proc Nat Acad Sci USA 2005; 102: 10604-9.

共引文献1

同被引文献62

引证文献3

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部